Showing results (261-270 of 10,059) with videos related to
Sort By:
Pageof 1,006
Current Pharmaceutical Design|May 14, 2020
Tribolium castaneum: A Model for Investigating the Mode of Action of Insecticides and Mechanisms of ResistanceJanin Rösner, Benedikt Wellmeyer, Hans MerzendorferCurrent Pharmaceutical Design|May 16, 2020
Chemoenzymatic Synthesis and Function of Chitin DerivativesMakoto OgataCurrent Pharmaceutical Design|August 5, 2022
Herbal Medicines as Potential Inhibitors of SARS-CoV-2 InfectionSoodabeh Rostami, Shima Gharibi, Hajar Yaghoobi, et al.Current Pharmaceutical Design|September 17, 2021
BDZs, Designer BDZs and Z-drugs: Pharmacology and Misuse InsightsSimona Zaami, Silvia Graziano, Roberta Tittarelli, et al.Current Pharmaceutical Design|August 1, 2022
Topoisomerase Enzyme Inhibitors as Potential Drugs Against Cancer: What Makes Them Selective or Dual? - A ReviewJoilly Nilce Santana Gomes, Mirelly Barbosa Santos, Yvnni Maria Sales de Medeiros E Silva, et al.Current Pharmaceutical Design|August 1, 2022
Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal CancerNima Zafari, Mahla Velayati, Mohammadreza Nassiri, et al.Current Pharmaceutical Design|September 3, 2021
Surgical Treatment of Pulmonary Embolism and Chronic Thromboembolic Pulmonary HypertensionNikolaos A Papakonstantinou, Polydoros N Kampaktsis, Filippos-Paschalis Rorris, et al.Current Pharmaceutical Design|August 24, 2025
Inclusion Complexes of α and β-cyclodextrin with Canagliflozin Hemihydrate: Design and CharacterizationPriyanka Gauniya, Chitra, Mukesh Pandey, et al.Current Pharmaceutical Design|May 26, 2015
Inflammation fuels tumor progress and metastasisJingyi Liu, Pengnian Charles Lin, Binhua P ZhouCurrent Pharmaceutical Design|May 26, 2015
Chronic inflammation and colorectal cancer: the role of vascular endothelial growth factorTao Hu, Long Fei Li, Jing Shen, et al.Pageof 1,006